Abstract
Albumin is the most abundant plasma protein produced by the liver and released in blood stream without storage. Its concentration is reduced by inflammation and liver disease. Hypoalbunemia is a common complication of cirrhosis and is associated with worsen outcome.
Albumin administration is indicated in large-volume paracentesis, in spontaneous bacterial peritonitis, and with vasopressor in hepatorenal syndrome.
In all this indication albumin is associated with reduced mortality.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Nicholson JP, Wolmarans MR, Park GR (2000) The role of albumin in critical illness. Br J Anaesth 85(4):599–610
Quinlan GJ, Martin GS, Evans TW (2005) Albumin: biochemical properties and therapeutic potential. Hepatology 41(6):1211–1219
Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R (2013) Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 58(5):1836–1846
Rozga J, Piątek T, Małkowski P (2013) Human albumin: old, new, and emerging applications. Ann Transplant 18:205–217
Rena NM, Wibawa ID (2010) Albumin infusion in liver cirrhotic patients. Acta Med Indones 42(3):162–168
Arroyo V, García-Martinez R, Salvatella X (2014) Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol 61(2):396–407
Bernardi M, Maggioli C, Zaccherini G (2012) Human albumin in the management of complications of liver cirrhosis. Crit Care 16(2):211
Caraceni P, Domenicali M, Tovoli A, Napoli L, Ricci CS, Tufoni M, Bernardi M (2013) Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med 24(8):721–728
Bernardi M, Caraceni P, Navickis RJ, Wilkes MM (2012) Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 55(4):1172–1181
Kwok CS, Krupa L, Mahtani A, Kaye D, Rushbrook SM, Phillips MG, Gelson W (2013) Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis. Biomed Res Int 2013:295153
Salerno F, Navickis RJ, Wilkes MM (2013) Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol 11(2):123–30.e1
Gluud LL, Christensen K, Christensen E, Krag A (2010) Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 51(2):576–584
Gluud LL, Christensen K, Christensen E, Krag A (2012) Terlipressin for hepatorenal syndrome. Cochrane Database Syst Rev (9):CD005162
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Krzych, Ł.J. (2015). Albumin Use in Liver Cirrhosis. In: Landoni, G., Mucchetti, M., Zangrillo, A., Bellomo, R. (eds) Reducing Mortality in Critically Ill Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-17515-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-17515-7_6
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17514-0
Online ISBN: 978-3-319-17515-7
eBook Packages: MedicineMedicine (R0)